We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure (CHF) Clinical Trial
	Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Chronic Heart Failure (CHF) Clinical Trial
	Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Thrombosis Clinical Trial
	Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Thrombosis Clinical Trial
	Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	Hepatitis C Virus(HCV) Heart and Lung Study
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	Hepatitis C Virus(HCV) Heart and Lung Study
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Cognitive Intervention to Improve Memory in Heart Failure Patients
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Cognitive Intervention to Improve Memory in Heart Failure Patients
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Atrial Septal Defect Clinical Trial
	Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
		Status: Enrolling
  
							
  	
	Atrial Septal Defect Clinical Trial
	Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Deep Venous Thrombosis Clinical Trial
	Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Deep Venous Thrombosis Clinical Trial
	Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure Clinical Trial
	Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure Clinical Trial
	Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
  
							
  	
	Coronary Artery Disease Clinical Trial
	RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Congenital Heart Defect Clinical Trial
	Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling
  
							
  	
	Congenital Heart Defect Clinical Trial
	Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Arrythmias Clinical Trial
	RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
		Status: Enrolling,
							Phase
  
							
  	
	Cardiac Arrythmias Clinical Trial
	RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology Clinical Trial
	Neuroprognostication Using Optic Nerve Sheath Diameter
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	Neuroprognostication Using Optic Nerve Sheath Diameter
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure (CHF) Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Thrombosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Hepatitis C Virus(HCV) Heart and Lung Study
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Cognitive Intervention to Improve Memory in Heart Failure Patients
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Atrial Septal Defect Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Deep Venous Thrombosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  RESOLUTE ONYX Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Congenital Heart Defect Clinical Trial
	
Updated: 12/31/1969
  
  
  Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Arrythmias Clinical Trial
	
Updated: 12/31/1969
  
  
  RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Physiologic Assessment of Coronary Stenosis Following PCI
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Neuroprognostication Using Optic Nerve Sheath Diameter
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Systolic Function Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	